Mozaffar, T., Bratkovic, D., Byrne, B., Clemens, P., Geberhiwot, T., Goker-Alpan, O., … Schoser, B. (2018). First-in-human Study of ATB200/AT2221 in Patients with Pompe Disease: Preliminary Results From the ATB200-02 Trial. In NEUROLOGY (Vol. 90). Los Angeles, CA: LIPPINCOTT WILLIAMS & WILKINS.

Mozaffar, Tahseen, Drago Bratkovic, Barry Byrne, Paula Clemens, Tarekegn Geberhiwot, Ozlem Goker-Alpan, Priya Kishnani, et al. “First-in-human Study of ATB200/AT2221 in Patients with Pompe Disease: Preliminary Results From the ATB200-02 Trial.” In NEUROLOGY, Vol. 90. LIPPINCOTT WILLIAMS & WILKINS, 2018.

Mozaffar T, Bratkovic D, Byrne B, Clemens P, Geberhiwot T, Goker-Alpan O, et al. First-in-human Study of ATB200/AT2221 in Patients with Pompe Disease: Preliminary Results From the ATB200-02 Trial. In: NEUROLOGY. LIPPINCOTT WILLIAMS & WILKINS; 2018.

Mozaffar, Tahseen, et al. “First-in-human Study of ATB200/AT2221 in Patients with Pompe Disease: Preliminary Results From the ATB200-02 Trial.” NEUROLOGY, vol. 90, LIPPINCOTT WILLIAMS & WILKINS, 2018.

Mozaffar T, Bratkovic D, Byrne B, Clemens P, Geberhiwot T, Goker-Alpan O, Kishnani P, Ming X, Roberts M, Schwenkreis P, Sivakumar K, van der Ploeg A, Wright J, Johnson F, Sitaraman S, Barth J, Sathe S, Schoser B. First-in-human Study of ATB200/AT2221 in Patients with Pompe Disease: Preliminary Results From the ATB200-02 Trial. NEUROLOGY. LIPPINCOTT WILLIAMS & WILKINS; 2018.